• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/18/2022
Event Type  malfunction  
Event Description
The user facility reported that the capiox oxygenator involved was used in an extracorporeal circulation operation at ordinary temperature for a patient with a re-operation (bsa: approx.1.5, target index: 2.5).Quadrox was used at the beginning of the operation.However, it became difficult for the co2 value to decrease on the way, so it was replaced with a fx15e.A little while after the replacement, it became difficult for the co2 value to decrease even with fx15, and even if it circulated at 3l or more, it did not improve significantly.Nevertheless, the surgery was successfully completed.(act: 1000 seconds or more, fx15 usage time: approx.50 minutes) the final impact of the patient was not harmed.Medical or surgical intervention was not required.
 
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual sample was returned for investigation.Visual inspection of the actual sample did not find any anomaly including a breakage that could lead to gas transfer failure.After rinsing and drying the actual sample, the amount of oxygen transfer and carbon dioxide gas removal were measured according to the product inspection procedure manual.It was confirmed to meet the factory's specifications and no anomaly was found in the gas transfer performance.[bovine blood conditions] hb: 12g/dl, temp.: 37°c., ph: 7.4, svo2: 65%, pvco2: 45mmhg.[circulation conditions] blood flow rate: 5l/min and 3l/min, v/q:1, fio2: 100%.[o2 transfer volume] @5l/min: 301ml/min., @3l/min: 200ml/min.[co2 removal volume] @5l/min: 248ml/min., @3l/min: 171ml/min.Review of the manufacturing history record and the product release decision control sheet of the actual sample confirmed that there were not any indications of anomaly in them.A search of the complaint file found no other similar report with the involved product code/lot number combination.Based on the investigation result, no anomaly was found in the gas transfer performance of actual sample after rinsing and drying.As a cause of occurrence, it was likely that since the pco2 of the blood flowing into the oxygenator was high for some reason, paco2 was also high.However, it was not possible to identify the cause of the increase in pco2 of the blood flowing into the oxygenator from the state of actual sample.Relevant ifu reference: measure blood gases and make necessary adjustments as follows: control pao2 by changing concentration of oxygen in ventilating gas using gas blender.To decrease pao2, decrease fio2.To increase pao2, increase fio2.Control paco2 by changing the total gas flow.To decrease paco2, increase total gas flow.To increase paco2, decrease total gas flow.(d.During perfusion).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
stephanie handy
reg. no. 2243441
265 davidson ave suite 320
somerset, NJ 08873
9499890491
MDR Report Key14414102
MDR Text Key292357947
Report Number9681834-2022-00088
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/16/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model NumberN/A
Device Catalogue NumberCX-FX15E
Device Lot Number201012
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/21/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/12/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-